Sharks have a fascinating immune system (and as far as we know, they don’t develop idiopathic pulmonary fibrosis (IPF). They can repair wounds and injuries quickly. Researchers even believe that the shark has a higher resistance to cancer.
What does this have to do with idiopathic pulmonary fibrosis (IPF)?
Well, researchers at Cornell University think that a shark’s biology can help them develop better treatments for diseases in humans. The BBC reported that the wobbegong shark’s blood sample was used to create a drug called AD-114. This drug works by targeting fibrosis-causing cells in the human. In fact, the drug would be getting rid of the disease before it worsens.
Stay tuned for the human trials in 2018. Hopefully this will cure IPF.
Trust me, you REALLY want to click here for a FASCINATING read on this!
